-
31 January 2012
-
12 December 2011
-
30 September 2011
-
26 September 2011
-
01 August 2011
-
06 July 2011
-
31 May 2011
Saving more lives with Artesunate Injection
This Stakeholders’ Meeting Report summarizes the key issues relating to the adoption and implementation of injectable artesunate in malaria-affected regions and outlines a set of recommended actions.
Access team
The Access team works closely with Ministries of Health, pharmaceutical partners, international agencies, and the global health community to lay the ground for access to the products in MMV's portfolio.



In partnership with the WHO and other normative bodies, MMV assists and expedites in-country processes to adopt new medicines.
MMV has begun to conduct an antimalarial market analysis in Africa to inform important access initiatives, such as the AMFm.